This prospective study with selected small group of patients showed that there is no difference of male pattern baldness in BPH and prostate cancer patients and also there is no correlation between pattern of baldness and serum androgen levels.

Background: We investigated whether the frequency of lower urinary tract symptoms (LUTS) increased in patients in whom double-J stents were applied. We also evaluated several medical therapy protocols to treat symptoms related with ureteral stents. Materials and Methods: A total of 108 patients, in whom unilateral double-j stent was applied during ureteral stone treatment, were included. Before the double-J stent was applied, all patients completed storage components of the "International Prostate Symptom Score" (IPSSs), quality of life components of the IPSS (IPSS-QOL) and "Overactive Bladder Questionnaire" (OABq) forms and scores were calculated. After the procedure, cases were randomized into 5 groups, an antiinflammatory was given to Group 1, spasmolytic to Group 2, anticholinergic to Group 3 and α-blocker to Group 4. No additional drug was given to Group 5 as this control group. During the fourth week of the procedure, IPSSs, IPSS-QOL and OABq forms were again completed and scores were compared with the previous ones. Results: When all the cases were evaluated, the IPSSs, IPSS-QOL and OABq scores of patients in whom the double-J stent was applied were statistically significantly higher the procedure. Compared to the control group, the cases where the double-J stent was applied showed a higher IPSSs, IPSS-QOL and OABq scores and none of the medical therapies could prevent this increase. Interpretation: The frequency of LUTS increased in cases where the ureteral stent was applied and discomfort continued as long as the stent stayed in the body. IntroductionCystoscopic intraluminal placement of ureteral stents has become a routine practice in urology. Ureteral stents preserve urine flow from the kidney to the bladder in cases of ureteral obstruction (intrinsic or extrincis). In patients with obvious ureteral obstruction, the placement of a ureteral stent will restart urine transport and protect the kidney from possible risks. The stents also prevent urine extravasation after an operation or trauma.One of the most preferred stents is the double-J stent with J-shaped ends on both sides. Ureteral double-j stents are generally placed for a temporary period. The duration of the stent may differ due to the reason of the application and the experience of the doctor. Although double-J stents are generally safe and well-tolerated, they have complications, such as pain, discomfort, urinary infection, recurrent obstruction, stent encrustation, stent fragmantation and stent migration. Their negative effects on quality of life and sexual functions have also been emphasized by some researchers.1,2 Research is ongoing in developing and validating questionnaires on symptoms related to ureteral stents and the effects of these symptoms on daily life.A way to reduce symptoms related with stents might be to alter the design and material of the stents. Researchers continue to study the effect of several medical therapies on reducing the negative symptoms which affect quality of life. 1,3 In this study, we investigated whet...

To evaluate the predictive value of some certain radiological as well as stone-related parameters for medical expulsive therapy (MET) success with an alpha blocker in ureteral stones. A total 129 patients receiving MET for 5 to 10 mm ureteral stones were evaluated. Patients were divided into two subgroups where MET was successful in 64 cases (49.61%) and unsuccessful in 65 cases (50.39%). Prior to management, stone size, location, position in the ureter, degree of hydronephrosis, diameter of ureteral lumen proximal to the stone, ureteral wall thickness along with patient's demographics including body mass index (BMI) values were evaluated and recorded. The possible predictive values of these parameters for stone expulsion (and stone expulsion time) were evaluated in a comparative manner between two groups. The overall mean patient age and stone size values were 38.02 ± 0.94 years and 40.31 ± 1.13 mm(2), respectively. Regarding the predictive values of these parameters for MET-success, while stone size and localization, degree of hydronephrosis, proximal ureteral diameter and ureteral wall thickness were found to be highly predictive for MET-success, patients age, BMI values and stone density had no predictive value on this aspect. Our findings indicated that some stone and anatomical factors may be used to predict the success of MET in an effective manner. With this approach unnecessary use of these drugs that may cause a delay for stone removal will be avoided and the possible adverse effects of obstruction as well as stone-related clinical symptoms could be minimized.

No abstract

Penile amputation is an uncommon condition that requires immediate surgical replantation. Routine standardized procedures for dealing with this medical condition do not exist. We describe a case of complete guillotine-type glans penis amputation and review the relevant literature. We performed urethral end-to-end approximation and glanular anastomosis and then applied hyperbaric oxygen therapy postoperatively. We obtained very good cosmetic and functional results.

The use of ureteral stents is a common procedure in urology practice. We investigated whether the use of double-J stent had an effect on sexual functions or not. One hundred and seventy-seven cases were included in the study. Unilateral double-J stent was placed during ureteral stone treatment in one hundred and eight of these cases. Sixty-nine cases were included as the control group. 'International Index of Erectile Function' (IIEF) and 'Female Sexual Function Index' (FSFI) questionaries were assessed before and 4 weeks after the intervention in all patients. When total IIEF and subdomains of IIEF scores of men and total FSFI and subdomains of FSFI scores of women whom double-J stent was placed were evaluated before and after the procedure, there was statistically significant reduction in patient's scores. In the control group, any statistically significant alteration in patient's score was not observed in men and women. Sexual functions are negatively affected in both women and men whom ureteral stents are placed. To reduce these problems specific to urinary system owing to stents, new treatment strategies and new studies that lead to improvements in the material and design of stents are required.

We evaluated the effectiveness of sildenafil citrate on lower urinary system symptoms (LUTS) by using symptom score scales. We also evaluated whether or not the presence of asymptomatic inflammatory prostatitis had an effect on the alteration in the symptom scores. A total of 36 male patients were included in the study. For all the cases, 'International Prostate Symptom Score' (IPSS), 'National Health Institute Chronic Prostatitis Symptom Index' (NIH-CPSI) and 'International Index of Erectile Function' (IIEF-5) were investigated and the scores were calculated in the first visit. Sildenafil citrate was given for 30 days and at the second visit IPSS, NIH-CPSI and IIEF-5 scores were once more analyzed. Afterwards, the alterations of the scores between visits were statistically compared. Mean age of the 36 cases included in the study was 59.03 ± 1.35. When the alterations in parameters of first visit and second visit were evaluated, we found a statistically significant increase in IIEF-5 and a statistically significant decrease in IPSS, IPSS-QOL (Quality of Life). In addition, when the cases were divided into two groups with and without asymptomatic inflammatory prostatitis, in the cases with asymptomatic inflammatory prostatitis, sildenafil citrate caused improvement only in ED, but had no effect on LUTS. Sildenafil citrate use in cases with LUTS and ED has an improving effect on LUTS as well as ED. However, in cases with asymptomatic inflammatory prostatitis, sildenafil citrate did not lead to an improvement in LUTS.

Objective: Sexual dysfunction considerably affects the life of patients with multiple sclerosis. In this study, we aimed to investigate the relationship between sexual dysfunction and the type and degree of multiple sclerosis in patients, in addition to the effects of sexual dysfunction on their quality of life.Material and methods: Fifty-eight patients (33 females and 25 males) with multiple sclerosis were included in the study. All of the patients underwent a detailed neurological examination, according to the clinical course of multiple sclerosis. For the assessment of quality of life, the Expanded Disability Status Scale (EDSS), Barthel Index (BI) for daily-life activities, and the Multiple Sclerosis Quality of Life-54 Instrument (MSQOL-54) were used. To determine sexual dysfunction, the Female Sexual Function Index (FSFI) and International Index of Erectile Function Questionnaire (IIEF) were used for females and males, respectively. The relationship between the scores of FSFI, IIEF and MSQOL-54, EDSS, BI was investigated. Results:The average age of the patients and the period of disease were 38.24±1.28 and 7.30±0.84 years, respectively. The mean scores were 2.88±0.26 for EDSS, 88.62±2.64 for BI, 59.10±2.90 for the mental health score of MSQOL-54 and 59.11±2.84 for physical health score of MSQOL-54. Sexual dysfunction was observed in 19 females (57.6%) and 16 males (64.0%) with MS. There were no statistically significant differences in the FSFI and IIEF scores among subtypes of multiple sclerosis (p>0.05). The FSFI and IIEF scores were correlated with MS quality of life scores. However, FSFI and IIEF were not correlated with the period of disease, EDSS or Barthel scores (p>0.05). Conclusion:Sexual dysfunction is frequently observed in multiple sclerosis patients. The decrease in quality of life due to sexual dysfunction is independent from the type of MS and the disability state of patients. ÖZET Amaç: Cinsel i §lev bozuklugu, multiple skleroz'lu (MS) bireylerin yaçammi oldukça etkilemektedir. Biz bu çaliçmada MS'li hastalarda görülen cinsel i §lev bozukiugunun hastalik tipi ve derecesi ile arasmdaki ili §kiyi ve ya §am kaiitesi üzerindeki etkisini ortaya koymayi amaçladik. Gereç ve yöntemler: Multiple skleroz'lu 58 hasta (25 erkek, 33 kadin) çali §maya alindi. Tüm hastalara MS'in klinik seyrine dayanan detayli görü §meyi de içeren tam nörolojik muayene yapildi. Geni §letilmi § özürlülük durum ölcegi (EDSS), günlük ya §am aktiviteleri (Barthel) indeksleri, MS ya §am kaiitesi sorgulamasi (MSQOL-54) ve cinsel i §lev bozuklugunu saptamak için kadinlarda FSFI (Kadin cinsel fonksiyon indeksi), erkeklerde IIEF (Uluslararasi erektil fonksiyon indeksi) kullanildi. FSFI, IIEF skorlari ile MSQOL-54, EDSS, Barthel skorlari arasinda ili §ki olup olmadigi araçtirildi.Bulgular: Hastalarin ortalama ya §i 38.24±1.28, hastalik süresi 7.30±0.84 yil idi. Ortalama EDSS 2.88±0.26, ortalama Barthell degeri 88.62±2.64, ortalama MSQOL-54 mental saglik skoru 59.10±2.90, fiziksel saglik skoru 59.11+2.84 olarak saptandi. Ondokuz kadin ...